Approximately 1.25 million Americans who live with Type 1 diabetes depend on insulin. An additional 5.75 million Americans with Type 2 diabetes require insulin to help their bodies thrive. However, as the cost of insulin continues to skyrocket, a staggering number are u ... Read more

What is Basaglar KwikPen? Basaglar insulin is a medication containing a recombinant human insulin protein that works in the body as a long-acting parenteral agent to lower blood glucose levels and maintain glycemic control. Basaglar differs slightly from traditional hu ... Read more

Fiasp vs. Novolog Fiasp and Novolog are insulin aspart medications. Both medications are fast acting and begin to work approximately 15 minutes after injection. The effects peak approximately 1 hour after injection and last for up to 4 hours. What are these medication ... Read more

How to Convert Insulin Products There are many reasons why patients may need to switch between insulin products. However, this decision should always be made with the approval of the prescriber. The switch should be closely monitored, including close monitoring on the ... Read more

Basaglar vs. Lantus Insulin Basaglar and Lantus are both insulin glargine medications. They are long-acting insulin analogues. Basaglar was approved in December 2015 and is a “follow-on” to Lantus. Basaglar is manufactured by Eli Lilly and Lantus is manufa ... Read more

When comparing Novolin R versus Novolog Insulin, you may notice a number of similarities and differences. What is Novolin R? First, Novolin R is chemically very similar to native human insulin, as both are produced by the bacteria Saccharomyces cerevisiae ... Read more